Indiana University Department of Neurology
Indianapolis, Indiana, United States
University department in Indianapolis, Indiana
355 W 16th St #4700, Indianapolis, IN 46202
About Indiana University Department of Neurology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
OPKO Health, Inc.
2
Artielle ImmunoTherapeutics
1
CENTOGENE GmbH Rostock
1
Cytokinetics
1
Eisai Inc.
1
Genentech, Inc.
1
Genzyme, a Sanofi Company
1
JANSSEN Alzheimer Immunotherapy Research & Development, LLC
1
TauRx Therapeutics Ltd
1
Clinical Trials at Indiana University Department of Neurology
During the past decade, Indiana University Department of Neurology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on
average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
AAB-001 in Patients With Mild to Moderate Alzheimer's Disease
2005-04-01
2008-12-01
Completed
234
Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis
2006-12-01
2009-05-01
Unknown status
34
Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two
2007-10-01
2011-09-01
Completed
840
ELND005 in Patients With Mild to Moderate Alzheimer's Disease
2007-12-01
2010-05-01
Completed
353
ELND005 Long-Term Follow-up Study in Subjects With Alzheimer's Disease
2009-06-01
2011-06-01
Completed
103
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
2013-05-01
2016-02-01
Completed
220
Study of Safety, Tolerability & Efficacy of CK-2017357 in Amyotrophic Lateral Sclerosis (ALS)
2012-10-01
2014-03-01
Completed
711
A Study of Crenezumab in Participants With Mild to Moderate Alzheimer Disease
2015-02-26
2019-03-26
Completed
77
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Indiana University Department of Neurology" #1 sponsor was "OPKO Health, Inc." with 2 trials, followed by "Artielle ImmunoTherapeutics" with 1 trials
sponsored, "CENTOGENE GmbH Rostock" with 1 trials sponsored, "Cytokinetics" with 1 trials sponsored and "Eisai Inc."
with 1 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Indiana University Department of Neurology"
#1 collaborator was "Bayer" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Indiana University Department of Neurology
According to Clinical.Site data, the most researched conditions in "Indiana University Department of Neurology" are
"Alzheimer Disease" (2 trials), "Alzheimer's Disease" (2 trials), "Multiple Sclerosis, Relapsing-Remitting" (2 trials), "Amyotrophic Lateral Sclerosis" (1 trials) and "Behavioral Variant Frontotemporal Dementia (bvFTD)" (1 trials). Many other conditions were trialed in "Indiana University Department of Neurology" in a lesser frequency.
Clinical Trials Intervention Types at Indiana University Department of Neurology
Most popular intervention types in "Indiana University Department of Neurology" are "Drug" (8 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Alemtuzumab 12 mg" (1 trials), "Alemtuzumab 24 mg" (1 trials), "CK-2017357" (1 trials) and "Crenezumab dose level 1" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Indiana University Department of Neurology
The vast majority of trials in "Indiana University Department of Neurology" are
10 trials for "All" genders.
Clinical Trials Status at Indiana University Department of Neurology
Currently, there are NaN active trials in "Indiana University Department of Neurology".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Indiana University Department of Neurology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Indiana University Department of Neurology, 2 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".